Sotuvning operatsion marjasi: ALX Oncology Holdings Inc. (ALXO)

alxoncology.com (ALXO) kompaniyasining korporativ logotipi

ALX Oncology Holdings (ALXO) o'z laboratoriyalarida ekologik toza filtrlash tizimlarini joriy etish orqali saraton immunoterapiyasini ishlab chiqmoqda. Operatsion marja spredi biznes samaradorligini namoyish etadi, bunda 0.00 ko'rsatkichi ushbu metrikaning miqdorini belgilaydi. Kompaniya efvorpacept qo'llanilishini kengaytirmoqda, yangi bozor segmentlarini egallash va dori vositalarining potentsial savdosini oshirish uchun maqsadli molekulalarni klassik ximioterapiya bilan birlashtirishni rejalashtirmoqda.

ALXO: ALX Oncology Holdings Inc. Operatsion foyda normasi 04.07.2022 - 20.11.2026

ALX Oncology Holdings - tahliliy kesimlar va asosiy koʻrsatkichlar (ALXO)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:ALXO, ALX Oncology Holdings
ALX Oncology Holdings Inc. asosiy tovari

Operatsion marja operatsion foydaning tushumga nisbati orqali asosiy biznesning samaradorligini aks ettiradi, bu esa investorlarga moliyaviy xarajatlar va soliqlarni hisobga olguncha kompaniyaning foyda ko'rish qobiliyatini baholash imkonini beradi. Efvapaseptning agressiv klinik sinovlari va CD47 blokatorlarining ishlab chiqilishi fonida, operatsion foyda marjasi tarixi ALX Oncology Holdings (ALXO) ning ulkan R&D investitsiyalari va joriy operatsion samaradorligi o'rtasidagi muvozanatni vizuallashtiradi.

ALX Oncology Holdings kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|IMCR - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi JANX (Janux Pharma)|Operatsion foyda koeffitsiyenti RCUS|Operatsion marja ZYME (Zymeworks)|Operatsion foyda normasi TNGX|iovance.com - Operatsion marja|Sotuvning operatsion rentabelligi Immatics Biotechnologies|Xencor, Inc. (XNCR) - Operatsion rentabellik|Compass Therapeutics - Operatsion foyda normasi|REPL (replimune.com) - Operatsion marja|Operatsion marja Lyell|Operatsion rentabellik Innate Pharma (IPHA)|PYXS: Operatsion foyda marjasi|Compugen - Sotuvning operatsion marjasi|IO Biotech, Inc. (IOBT) - Sotuvning operatsion rentabelligi|STRO - Operatsion rentabellik|MiNK Therapeutics (INKT) - Sotuvning operatsion marjasi|HOWL: Operatsion marja|Sotuvning operatsion marjasi Immix|Sotuvning operatsion marjasi CUE|PDS Biotechnology Corporation (PDSB) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Operatsion marja MAIA Biotechnology Inc (MAIA)|Operatsion rentabellik Liminatus Pharma LIMN|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja